Literature DB >> 12932352

Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.

Achal Pashine1, Robert Busch, Michael P Belmares, Jason N Munning, Robert C Doebele, Megan Buckingham, Gary P Nolan, Elizabeth D Mellins.   

Abstract

HLA-DM (DM) edits major histocompatibility complex class II (MHCII)-bound peptides in endocytic compartments and stabilizes empty MHCII molecules. Crystal structures of DM have revealed similarity to MHCII but not how DM and MHCII interact. We used mutagenesis to map a MHCII-interacting surface on DM. Mutations on this surface impair DM action on HLA-DR and -DP in cells and DM-dependent peptide loading in vitro. The orientation of DM and MHCII predicted by these studies guided design of soluble DM and DR molecules fused to leucine zippers via their beta chains, resulting in stable DM/DR complexes. Peptide release from the complexes was fast and only weakly sequence dependent, arguing that DM diminishes the selectivity of the MHCII groove. Analysis of soluble DM action on soluble DR/peptide complexes corroborates this conclusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932352     DOI: 10.1016/s1074-7613(03)00200-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  52 in total

1.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

3.  Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

Authors:  Timo Burster; Henriette Macmillan; Tieying Hou; James Schilling; Phi Truong; Bernhard O Boehm; Fang Zou; Kenneth Lau; Michael Strohman; Steven Schaffert; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-03-17       Impact factor: 7.397

4.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

5.  Three-dimensional structure determines the pattern of CD4+ T-cell epitope dominance in influenza virus hemagglutinin.

Authors:  Samuel J Landry
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

6.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

7.  Small molecules that enhance the catalytic efficiency of HLA-DM.

Authors:  Melissa J Nicholson; Babak Moradi; Nilufer P Seth; Xuechao Xing; Gregory D Cuny; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

8.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

10.  The MHC class II cofactor HLA-DM interacts with Ig in B cells.

Authors:  Henriette Macmillan; Michael J Strohman; Sashi Ayyangar; Wei Jiang; Narendiran Rajasekaran; Armin Spura; Ann J Hessell; Anne-Marie Madec; Elizabeth D Mellins
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.